News

Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from ...
Mounjaro, initially for type 2 diabetes, gains popularity for weight loss, yet users report severe side effects. Ellie Marie, ...
GLP-1s such as semaglutide and tirzepatide, originally formulated to treat patients with diabetes, have been touted as a solution for weight loss.
The NBA Hall of Famer joined forces with the telehealth platform to restart his weight loss journey and raise awareness about ...
Over the past several decades, epidemiologic studies have documented declines in sperm count and quality. During the same ...
Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...
Shares of Hims & Hers Health skyrocketed to 40% in the premarket following the telehealth company’s partnership announcement ...
A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.
Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...
Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.
Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...